Risk stratification by minimal residual disease detection and ctDNA dynamics from personalised assays in stage II-III colorectal cancer in a UK multi-centre prospective study (TRACC Part B)
Susanna Slater, Christopher CT Sng, Gayathri Anandappa, Hsiang-Chi Chen et autres